The nutritional treatments also modulated other AD-associated factors, such as BACE1 (beta-secretase which processes APP at the beginning of the amyloidogenic pathway) but with mechanisms that are not mechanistically associated with DNA methylation [15,16,17]. Here, APP is linked to Alzheimer disease.